cancer vaccine

Biotech

CureVac rethinks lead cancer program after posting PD-1 data

CureVac has vowed to only consider further clinical studies if the drug candidate is paired with “a defined mRNA cancer vaccine.”
Nick Paul Taylor Nov 16, 2022 8:30am

BioNTech lines up 5 infectious disease trials for 2023

Nov 7, 2022 6:57am

Moderna optimisitic on ex-COVID programs as key readouts near

Nov 3, 2022 11:03am

Merck ditches Cavatak more than 4 years after buying Viralytics

Oct 27, 2022 10:40am

Merck gains Moderna's cancer shot, signs Royalty collab

Oct 12, 2022 10:55am

Taiwan's OBI Pharma drops cancer antibody over trial results

Jul 6, 2022 9:55am